Dr Reddys Laboratories receives EIR for facility at Duvvada
Dr Reddys Laboratories has received the Establishment Inspection
Report (EIR) from USFDA, for the company's formulations manufacturing facility at Duvvada, Visakhapatnam (Vizag SEZ Plant 1- FTO 7), indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 21 2020 | 4:57 PM IST